Treatment Failure with Nitrofurantoin in a Male Patient with S. epidermidis UTI
This patient requires immediate treatment with a different antibiotic based on culture susceptibilities, as nitrofurantoin has failed and the infection represents a complicated UTI in a male patient. 1
Why Nitrofurantoin Failed
The FDA label for Macrobid explicitly warns that "many patients who are treated with Macrobid are predisposed to persistence or reappearance of bacteriuria" due to its lack of broader tissue distribution. 2 The label specifically states that "if persistence or reappearance of bacteriuria occurs after treatment with Macrobid, other therapeutic agents with broader tissue distribution should be selected." 2
This is particularly critical in males, where any UTI is classified as complicated because prostate involvement cannot be excluded without specific examination findings. 1 Nitrofurantoin achieves inadequate tissue penetration in prostatic tissue, making it a suboptimal choice for men. 3, 4
Classification: This is a Complicated UTI
According to the 2024 EAU guidelines, UTI in males is automatically considered complicated. 1 The patient's persistent symptoms after appropriate treatment duration indicate either:
- Treatment failure due to inadequate tissue penetration
- Possible prostatic involvement (which cannot be excluded)
- Potential resistance (though S. epidermidis is typically susceptible to nitrofurantoin)
Immediate Management Steps
Obtain antibiotic susceptibilities from the culture immediately and select an appropriate agent based on the susceptibility pattern. 1
Recommended Antibiotic Selection (based on susceptibilities):
For complicated UTI in males with persistent symptoms, the 2024 EAU guidelines recommend 7-14 days of treatment (14 days when prostatitis cannot be excluded). 1
First-line empiric options while awaiting susceptibilities:
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7-14 days (if local resistance <20%) 1
- Fluoroquinolones (ciprofloxacin 500-750 mg twice daily for 7-14 days) only if local resistance <10% and patient hasn't used fluoroquinolones in the last 6 months 1
Once susceptibilities are available, tailor therapy to the most narrow-spectrum agent that covers S. epidermidis with adequate tissue penetration.
Critical Considerations for S. epidermidis
S. epidermidis causing symptomatic UTI in males is uncommon but well-documented, particularly in patients with:
- Nephrolithiasis (check for stones with imaging if not done)
- Diabetes
- Urological abnormalities 5
This organism can cause pyelonephritis and bacteremia, even without indwelling devices. 5 The persistence of symptoms raises concern for upper tract involvement or prostatic infection.
Clinical Assessment Required
Before prescribing, assess for:
- Fever, flank pain, or systemic symptoms → suggests pyelonephritis requiring longer treatment (10-14 days)
- Perineal pain, obstructive symptoms → suggests prostatitis requiring 14 days minimum
- Suprapubic tenderness only → lower tract infection, 7 days may suffice
Common Pitfalls to Avoid
- Do not retreat with nitrofurantoin - the FDA label explicitly warns against this approach 2
- Do not assume this is simple cystitis - all male UTIs are complicated by definition 1
- Do not use short 3-5 day courses - males require 7-14 days depending on suspected site of infection 1
- Do not empirically use fluoroquinolones without considering local resistance patterns - should only be used if resistance <10% 1